Alteri, Claudia <br/><br/>
The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate+emtricitabine-containing HAART both in vivo and in vitro.  [electronic resource] 

 -  Journal of global antimicrobial resistance  12 2016 
 - 1-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2213-7173 
<br/><br/><label>Standard No.: </label>10.1016/j.jgar.2016.06.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--pharmacology<br/>Antiretroviral Therapy, Highly Active<br/>Emtricitabine--pharmacology<br/>Female<br/>HIV Infections--drug therapy<br/>HIV Reverse Transcriptase--genetics<br/>HIV-1--drug effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Polymorphism, Genetic<br/>Tenofovir--pharmacology